1,067 followers
Cost-effectiveness analysis (CEA) of IMRT plus C12 boost vs IMRT only in adenoid cystic carcinoma (ACC) of the head and neck. https://t.co/nOgCNhdzS6 H/T @NCBI #radonc #PubMed
Cost-effectiveness analysis (CEA) of IMRT plus C12 boost vs IMRT only in adenoid cystic carcinoma (ACC) of the head and neck. https://t.co/nOgCNhdzS6 H/T @NCBI #radonc #PubMed